期刊： EXPERT OPINION ON DRUG SAFETY, 2021; 20 (9)
Backgrounds Acute pancreatitis (AP) has been reported in patients treated with protease inhibitors (PIs), but there are few real-world studies compari......
期刊： EXPERT OPINION ON DRUG SAFETY, 2021; 20 (8)
Background We compared the efficacy and safety of combinations of cyclin-dependent kinase 4/6 (CDK4/6) inhibitors and PI3K/AKT/mTOR inhibitors as seco......
期刊： EXPERT OPINION ON DRUG SAFETY, 2021; 20 (9)
Introduction: Many drugs are known to induce malignant syndromes. The most common malignant syndromes are induced by the use of antipsychotics and ane......
期刊： EXPERT OPINION ON DRUG SAFETY, 2020; 19 (2)
Introduction: Lacosamide has been used in epilepsy patients in the United States, Europe and Asia since it was approved by the FDA in 2008. Many patie......
期刊： EXPERT OPINION ON DRUG SAFETY, 2020; 19 (5)
Background: Terlipressin can effectively control acute gastrointestinal bleeding (GIB) in cirrhotic patients by acting on the V1 receptors, but may le......
期刊： EXPERT OPINION ON DRUG SAFETY, 2020; 19 (5)
Introduction: Lung cancer is the most prevalent malignant tumors worldwide. Over the past decade, the emergence of epidermal growth factor receptor-ty......
期刊： EXPERT OPINION ON DRUG SAFETY, 2020; 19 (8)
Objectives Rigorous clinical trials suggest ketamine is safe and well-tolerated in patients with treatment-resistant depression (TRD). There is a pauc......
期刊： EXPERT OPINION ON DRUG SAFETY, 2019; 18 (1)
Background: High-quality adverse drug reaction (ADR) reports are essential for conducting drug safety monitoring in pharmacovigilance. The study aim w......
期刊： EXPERT OPINION ON DRUG SAFETY, 2019; 18 (1)
Background: Although China's adverse drug reaction (ADR) reporting and monitoring has developed rapidly, many challenges remain. This study assessed A......
期刊： EXPERT OPINION ON DRUG SAFETY, 2019; 18 (3)
Introduction: Direct oral anticoagulants (DOACs) may be regarded as some of the most successful innovations in recent times. These drugs which were sp......
期刊： EXPERT OPINION ON DRUG SAFETY, 2019; 18 (5)
Objectives: This study aimed to develop a procedure to explore the adverse drug reaction signals of drug-induced neutropenia (DIN) or drug-induced agr......
期刊： EXPERT OPINION ON DRUG SAFETY, 2019; 18 (6)
Introduction: Nicorandil may exert cardioprotective effects in ischemic heart disease. However, its efficacy in combination with early reperfusion is ......
期刊： EXPERT OPINION ON DRUG SAFETY, 2019; 18 (9)
Objectives: There is a lack of direct evidence for the management of perioperative medications in elderly patients. Therefore, the authors aimed to de......
期刊： EXPERT OPINION ON DRUG SAFETY, 2019; 18 (10)
Objectives: The objectives were to identify drugs related with anemia in children and evaluate the novelty of these correlations. Methods: The authors......
